bbv152

Rediff.com » News » bbv152

News for bbv152

News

'Poorly designed': ICMR on BHU Covaxin safety study

The Indian Council of Medical Research Director General Dr Rajiv Bahl on Monday criticised a recently published study on the long-term safety analysis of the Covaxin in adults and adolescents for......

Over 30% Covaxin takers reported adverse events: Study

Nearly one-third of 926 individuals who received Bharat Biotech's anti-Covid vaccine Covaxin reported 'adverse events of special interest,' or AESI, according to a one-year follow up study......

Covid vax didn't increase risk of sudden death among young: Govt

A study conducted by the Indian Council of Medical Research (ICMR) has observed that COVID-19 vaccination did not increase the risk of unexplained sudden death among young adults in India, the......

Covaxin recommended by expert panel for 2-18 years

An expert panel of India's central drug authority has recommended granting emergency use authorisation to Bharat Biotech's Covaxin for children in the 2 to 18 years age group with certain......

Covaxin safe for children: Bharat Biotech

IMAGE: An Auxiliary Nurse Midwife healthcare worker inoculating a beneficiary with a dose of the COVID-19 vaccine during a door to door vaccination campaign at Margomunda, in Deoghar, Jharkhand,......

Rediff News

bbv152

News for bbv152

'Poorly designed': ICMR on BHU Covaxin safety study

Over 30% Covaxin takers reported adverse events: Study

Covid vax didn't increase risk of sudden death among young: Govt

Covaxin recommended by expert panel for 2-18 years

Covaxin safe for children: Bharat Biotech

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS